#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malformation venous Congenital disorder of glycosylation Neuropathic arthropathy PIK3CA-activated mutation Lip and/or oral cavity cancer Non-small cell lung cancer Raynaud's phenomenon Penile squamous cell carcinoma Osteosarcoma metastatic Oesophageal achalasia Bronchopulmonary aspergillosis Congenital pseudarthrosis Adenocarcinoma gastric Gastrointestinal disorder Hyperchylomicronaemia More trials…

    Learn about Rare Diseases

    Isodicentric chromosome 15 syndrome – Diagnostics Alveolar rhabdomyosarcoma Cytokine release syndrome – Life with Disease Skin angiosarcoma – Treatment Alport’s syndrome – Diagnostics Pleomorphic leiomyosarcoma – Trials in Disease Small intestine leiomyosarcoma – Treatment Chondrosarcoma – Diagnostics Lymphangiosarcoma – Diagnostics Breast angiosarcoma metastatic – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lorundrostat Ace Inhibitors, Plain Canis Familiaris (553) Biotin ABBV-CLS-628 Ceftriaxone Sodium Ion440 Napabucasin Gozetotide Encaleret Sulfate Timrepigene Emparvovec Bgb-15025 Citrate Mebeverine Hydrochloride L-Histidine Hydrochloride Treprostinil Caraway Oil Gd2Il18Cart Pamapimod Aup1602-C Rhh646 More therapies…

    Learn about Your Condition

    Toxic nodular goitre Androgenetic alopecia Mechanical ventilation Gaucher's disease type III Epithelioid sarcoma Testis cancer Hypophosphatasia Autoimmune uveitis Acute lymphocytic leukaemia Osteosarcoma metastatic Infertility male Rheumatoid arthritis Laryngeal cancer stage I Chorea Bipolar disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer

  • Study of Chemotherapy vs. Nivolumab for Patients with Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Nivolumab
    Spain

  • Study of Alectinib and Platinum-Based Chemotherapy for Patients with Resected Stage Ib to IIIa ALK-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Anaplastic lymphoma kinase gene mutation
    • Non-small cell lung cancer
    Investigated Drugs:
    • Vinorelbine
    • Alectinib
    • Carboplatin
    Austria Denmark France Germany Greece Hungary +4

  • Study on Vudalimab or Pembrolizumab with Chemotherapy for Advanced Non-small Cell Lung Cancer Patients

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Vudalimab
    • Carboplatin
    • Pembrolizumab
    Belgium Greece The Netherlands Poland Portugal Romania +1

  • Study of Durvalumab in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Durvalumab
    Belgium

  • Study on PET Tracers [18F]F-AraG and [89Zr]Zr-Df-Crefmirlimab for Evaluating T Cell Activation in Non-Small Cell Lung Cancer Patients

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Nelarabine
    • Zirconium (89Zr) Crefmirlimab Berdoxam
    The Netherlands

  • Study of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Selpercatinib
    Austria Belgium Czechia Denmark France Germany +8
Previous Page
1 … 37 38 39 40 41 … 54
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!